Cargando…
The efficacy of conbercept or ranibizumab intravitreal injection combined with laser therapy for Coats’ disease
PURPOSE: The current treatment approaches for Coats’ disease by intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents (ranibizumab or conbercept) combined with laser therapy were evaluated for the efficacy during the treatment. METHODS: The medical records of 28 patients di...
Autores principales: | Zhang, Longli, Ke, Yifeng, Wang, Wei, Shi, Xueying, Hei, Kaiwen, Li, Xiaorong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006222/ https://www.ncbi.nlm.nih.gov/pubmed/29549425 http://dx.doi.org/10.1007/s00417-018-3949-1 |
Ejemplares similares
-
Switching to Conbercept in Diabetic Macular Edema After Unsatisfactory Response to Previous Intravitreal Injection of Ranibizumab
por: Xing, Peiyu, et al.
Publicado: (2023) -
Intravitreal ranibizumab or conbercept for retinal arterial macroaneurysm: a case series
por: Lin, Zhongjing, et al.
Publicado: (2019) -
Comparison of the Efficacy and Safety of Intravitreal Conbercept with Intravitreal Ranibizumab for Treatment of Diabetic Macular Edema: A Meta-Analysis
por: Sun, Xiaolei, et al.
Publicado: (2020) -
Response to Comment on: Quantification of anterior chamber reaction after intravitreal injections of conbercept and ranibizumab: a pilot study
por: Liao, Xulong, et al.
Publicado: (2019) -
Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy
por: Cui, Jinglin, et al.
Publicado: (2018)